A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery
Clinical trial NCT03251482 · COMPLETED
Trial details
- NCT number
- NCT03251482
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-13
- Primary completion
- 2018-11-05
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.